# CytomX Therapeutics, Inc.: Form 8-K, filed Mar 23, 2022

- Company: [CytomX Therapeutics, Inc.](/companies/ctmx.md) (CIK 1501989)
- Form: 8-K
- Filed: 2022-03-23
- Accepted by EDGAR: Mar 23, 2022, 16:33 ET
- Period: 2022-03-23
- Accession: 0001193125-22-082793
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501989/000119312522082793/d340177d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501989/000119312522082793/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501989/000119312522082793/d340177d8k.htm

Filed Mar 23, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-082793. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
